Targeted Inhibition of Myeloperoxidase (MPO): A New Therapeutic Strategy for the Treatment of Multiple Myeloma

被引：1
|
作者：
Williams, Connor [1 ,2 ]
Noll, Jacqueline [1 ,2 ]
Harnas, Dylan [1 ,2 ]
Parkinson, Hayley [1 ,2 ]
Hewett, Duncan [1 ,2 ]
Wyllie, Kaitlin [3 ]
Cox, Thomas [3 ]
Zannettino, Andrew [1 ,2 ]
Vandyke, Kate [1 ,2 ]
Panagopoulos, Vasilios [1 ,2 ]
机构：
[1] Univ Adelaide, Sch Biomed, Fac Hlth & Med Sci, Myeloma Res Lab, Adelaide, SA, Australia
[2] South Australian Hlth & Med Res Inst, Precis Canc Med Theme, Adelaide, SA, Australia
[3] Garvan Inst, Matrix & Metastasis Lab, Sydney, NSW, Australia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179196
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Aminopeptidase inhibition as a targeted treatment strategy in myeloma
    Davies, Faith E.
    Moore, Hannah E.
    Davenport, Emma L.
    Dunlop, Alan S.
    Muralikrishnan, Srikanth
    Krige, David
    Hooftman, Leon
    Morgan, Gareth
    BLOOD, 2007, 110 (11) : 738A - 739A
  • [2] Aminopeptidase inhibition as a targeted treatment strategy in myeloma
    Moore, Hannah E.
    Davenport, Emma L.
    Smith, Emma M.
    Muralikrishnan, Srikanth
    Dunlop, Alan S.
    Walker, Brian A.
    Krige, David
    Drummond, Alan H.
    Hooftman, Leon
    Morgan, Gareth J.
    Davies, Faith E.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (04) : 762 - 770
  • [3] Immunomodulation as a therapeutic strategy in the treatment of multiple myeloma
    Mitsiades, Constantine S.
    Chen-Kiang, Selina
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 : S5 - S13
  • [4] A new therapeutic strategy with methotrexate-albumin in multiple myeloma?
    Lannert, H
    Salzer, M
    Hartung, G
    Ho, AD
    Goldschmidt, H
    BLOOD, 2000, 96 (11) : 289B - 289B
  • [5] BELANTAMAB MAFODITIN, A NEW THERAPEUTIC STRATEGY IN REFRACTORY MULTIPLE MYELOMA
    Garcia, Bacelar A.
    Garcia, De Coca A.
    Cuello, Garcia R.
    Bourgeois, Garcia E.
    De La Fuente, Graciani, I
    Caballero, Berrocal J. C.
    Gomez, Garcia L.
    Golvano, Guerrero E.
    Perez, Gonzalez S.
    Perez, Martinez C.
    Bombin, Canal C.
    Cebeira, Moro M. J.
    Acevedo, Garcia R.
    Tamayo, Velasco A.
    Herrera, Robles K.
    Penarrubia, Ponce M. J.
    HAEMATOLOGICA, 2021, 106 (10) : 135 - 135
  • [6] NEW THERAPEUTIC APPROACHES IN THE TREATMENT OF MULTIPLE-MYELOMA
    HAROUSSEAU, JL
    ANNALES DE MEDECINE INTERNE, 1989, 140 (01): : 45 - 49
  • [7] THERAPEUTIC STRATEGY IN MULTIPLE-MYELOMA
    DURIE, BGM
    SALMON, S
    BULLETIN DU CANCER, 1980, 67 (04) : 450 - 457
  • [8] Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma
    Amundarain, Ane
    Pastor, Fernando
    Prosper, Felipe
    Agirre, Xabier
    CANCERS, 2022, 14 (21)
  • [9] Current Therapeutic Strategy for Multiple Myeloma
    Suzuki, Kenshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 116 - 124
  • [10] INTERFERON - A NEW STRATEGY IN THE TREATMENT OF MULTIPLE-MYELOMA
    MANDELLI, F
    AVVISATI, G
    PETRUCCI, MT
    EUROPEAN JOURNAL OF HAEMATOLOGY, SUPPL NO 51, VOL 43, 1989: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MULTIPLE MYELOMA - BIOLOGY, PATHOPHYSIOLOGY, PROGNOSIS AND TREATMENT, 1989, : 129 - 134
12345